Is atomoxetine (Strattera) safe to prescribe to a patient with a family history of bipolar disorder?

Atomoxetine Safety in Patients with Family History of Bipolar Disorder

Atomoxetine can be prescribed to patients with a family history of bipolar disorder, but requires careful screening for personal bipolar risk and close monitoring for emergence of manic/hypomanic symptoms. A family history alone is not a contraindication, but demands heightened vigilance.

Key Distinction: Family History vs. Personal Diagnosis

The critical issue is whether the patient has a personal history of bipolar disorder versus only a family history:

For Family History Only (No Personal Bipolar Disorder):

• Atomoxetine is generally safe to prescribe 1
• The FDA label specifically addresses screening requirements: "prior to initiating treatment with STRATTERA, patients with comorbid depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression" 1
• This indicates family history is a risk factor requiring screening, not an absolute contraindication

Required Pre-Treatment Screening:

Before prescribing atomoxetine to someone with family history of bipolar disorder, you must:

1. Obtain detailed psychiatric history focusing on:

   • Any prior manic, hypomanic, or mixed episodes
   • Periods of decreased need for sleep with increased energy
   • Uncharacteristic impulsive behavior or risk-taking
   • Severe mood swings or irritability
   • Response to prior antidepressants (did they trigger activation?)

2. Screen for current depressive symptoms that might mask bipolar disorder 1

3. Document family psychiatric history including:

   • Bipolar disorder in first-degree relatives
   • Suicide attempts or completions
   • Depression requiring hospitalization

Monitoring During Treatment

The FDA label warns that "treatment emergent psychotic or manic symptoms, e.g., hallucinations, delusional thinking, or mania in children and adolescents without a prior history of psychotic illness or mania can be caused by atomoxetine at usual doses" 1. This occurred in approximately 0.2% of patients in pooled analyses.

Monitor specifically for:

• New onset irritability, agitation, or hostility
• Decreased need for sleep
• Racing thoughts or pressured speech
• Grandiosity or inflated self-esteem
• Increased goal-directed activity or psychomotor agitation
• Impulsive or risky behavior

If any manic/hypomanic symptoms emerge: "consideration should be given to a possible causal role of atomoxetine, and discontinuation of treatment should be considered" 1

Evidence from Comorbid Bipolar-ADHD Populations

While your question concerns family history only, data from patients with actual bipolar disorder provides context on atomoxetine's mood effects:

• In stabilized bipolar patients on mood stabilizers, atomoxetine showed efficacy for ADHD with low but non-zero risk of mood destabilization 2, 3, 4
• A 2017 case report documented atomoxetine-induced hypomania even in a stabilized bipolar patient on mood stabilizers 5
• A comprehensive 2016 safety review found psychosis/mania symptoms were "mainly observed in patients with comorbid bipolar disorder/depression" 6

Clinical implication: If atomoxetine carries some risk even in diagnosed, stabilized bipolar patients on mood stabilizers, vigilance is warranted in those with family history who may have undiagnosed bipolar vulnerability.

Common Pitfalls to Avoid

1. Don't dismiss family history as irrelevant - it increases risk of bipolar disorder and requires active screening
2. Don't confuse ADHD symptoms with hypomania - both can present with distractibility and impulsivity; look for episodic nature and decreased sleep need in hypomania
3. Don't assume initial stability means no risk - manic symptoms can emerge weeks into treatment
4. Don't continue atomoxetine if mood symptoms emerge - the FDA explicitly recommends considering discontinuation 1

Bottom Line Algorithm

YES, prescribe atomoxetine if:

• Thorough screening reveals no personal history of mania/hypomania
• No current depressive symptoms suggesting possible bipolar depression
• Patient/family can reliably monitor for mood changes

Establish monitoring plan:

• Follow-up within 2-4 weeks of initiation
• Educate patient/family about warning signs of mania/hypomania
• Lower threshold for discontinuation if mood symptoms emerge

The family history makes screening mandatory but does not prohibit atomoxetine use when that screening is negative 1.